Enhanced recovery after surgery with laparoscopic radical gastrectomy for stomach carcinomas

To study the efficacy of the enhanced recovery after surgery (ERAS) program in laparoscopic radical gastrectomy for stomach carcinomas. From June 2010 to December 2012, 61 gastric cancer patients who underwent laparoscopic-assisted radical gastrectomy with D2 lymphadenectomy at First Hospital of Jil...

Full description

Saved in:
Bibliographic Details
Published in:World journal of gastroenterology : WJG 2015-12, Vol.21 (47), p.13339-13344
Main Authors: Abdikarim, Ikram, Cao, Xue-Yuan, Li, Shou-Zhen, Zhao, Yin-Quan, Taupyk, Yerlan, Wang, Quan
Format: Article
Language:English
Subjects:
Aged
Carcinoma - secondary
Carcinoma - surgery
China
Clinical Trials Study
Female
Gastrectomy - adverse effects
Gastrectomy - methods
Humans
Laparoscopy - adverse effects
Length of Stay
Lymph Node Excision
Lymphatic Metastasis
Male
Middle Aged
Postoperative Care
Prospective Studies
Recovery of Function
Stomach Neoplasms - pathology
Stomach Neoplasms - surgery
Time Factors
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To study the efficacy of the enhanced recovery after surgery (ERAS) program in laparoscopic radical gastrectomy for stomach carcinomas. From June 2010 to December 2012, 61 gastric cancer patients who underwent laparoscopic-assisted radical gastrectomy with D2 lymphadenectomy at First Hospital of Jilin University were enrolled in this randomized controlled trial. (Clinical Trials.gov, registration ID: NCT01955096). The subjects were divided into the ERAS program group and the conventional control group. The clinical characteristics, recovery variables, and complications of patients were analyzed. The time to first ambulation, oral food intake, and time to defecation were significantly shorter in the ERAS group (n = 30), compared to the conventional group (n = 31; P = 0.04, 0.003, and 0.01, respectively). The postoperative hospital stay was less in the ERAS group (6.8 ± 1.1 d) compared to the conventional group (7.7 ± 1.1 d) (P = 0.002). There was no significant difference in postoperative complications between the ERAS (1/30) and conventional care groups (2/31) (P = 1.00). There were no readmissions or mortality during the 30-d follow-up period. The ERAS program is associated with a shorter hospital stay in gastric cancer patients undergoing laparoscopic radical gastrectomy. The ERAS protocol is useful in the treatment of gastric cancer.
ISSN:1007-9327
2219-2840
DOI:10.3748/wjg.v21.i47.13339